[Article presse ] Par Frédéric Thual- La Tribune , à Nantes | 26/03/2020, 15:08 Avec...More
Français ci-dessous « We are convinced that our treatment will be efficient, for...More
[Article Presse] Par Emmanuel Guimard Publié le 20 mars 2020 à 17h14...More
[Communiqué ] Nantes , le 19 mars 2020 XENOTHERA pense détenir aujourd’hui...More
Nantes, September 11th, 2019 – XENOTHERA announces it has received Czech Republic regulatory...More
XENOTHERA announces receivability of its Clinical Trial Application at the Czech Republic regulatory agency for a first in man clinical trial of LIS1 in kidney transplanted patients with dose escalation.
Nantes, June 21st, 2019 – XENOTHERA announces receivability after its submission of a Clinical...More